Free Trial

Teacher Retirement System of Texas Takes Position in Integer Holdings Corporation (NYSE:ITGR)

Integer logo with Medical background

Teacher Retirement System of Texas acquired a new position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 4,903 shares of the medical equipment provider's stock, valued at approximately $579,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Proficio Capital Partners LLC acquired a new stake in Integer in the fourth quarter valued at $2,195,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Integer by 3.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,904 shares of the medical equipment provider's stock valued at $782,000 after purchasing an additional 180 shares during the last quarter. HighTower Advisors LLC grew its holdings in Integer by 1.4% in the fourth quarter. HighTower Advisors LLC now owns 12,207 shares of the medical equipment provider's stock valued at $1,618,000 after purchasing an additional 166 shares during the last quarter. Swiss National Bank grew its holdings in Integer by 0.8% in the fourth quarter. Swiss National Bank now owns 65,900 shares of the medical equipment provider's stock valued at $8,733,000 after purchasing an additional 500 shares during the last quarter. Finally, Royce & Associates LP grew its holdings in Integer by 31.9% in the fourth quarter. Royce & Associates LP now owns 61,759 shares of the medical equipment provider's stock valued at $8,184,000 after purchasing an additional 14,919 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently commented on ITGR shares. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and increased their price objective for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Benchmark decreased their price objective on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Raymond James Financial increased their price objective on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Finally, Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Integer presently has an average rating of "Moderate Buy" and an average target price of $146.25.

View Our Latest Stock Analysis on Integer

Integer Stock Down 1.9%

NYSE ITGR traded down $2.13 during mid-day trading on Friday, reaching $112.51. 463,003 shares of the company's stock traded hands, compared to its average volume of 390,078. Integer Holdings Corporation has a 1-year low of $104.93 and a 1-year high of $146.36. The company has a fifty day simple moving average of $119.65 and a 200-day simple moving average of $124.39. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78. The company has a market cap of $3.93 billion, a price-to-earnings ratio of 53.32, a P/E/G ratio of 0.97 and a beta of 0.98.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The business's revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.14 EPS. As a group, equities research analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current year.

Insider Activity at Integer

In other news, Director Donald J. Spence sold 14,739 shares of the business's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total value of $1,774,280.82. Following the sale, the director owned 18,781 shares of the company's stock, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer directly owned 47,000 shares in the company, valued at $5,788,990. This represents a 87.82% decrease in their position. The disclosure for this sale can be found here. Insiders sold 362,434 shares of company stock worth $44,577,115 in the last 90 days. 2.16% of the stock is currently owned by company insiders.

Integer Profile

(Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Recommended Stories

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines